Advertisement

Topics

Yuhan Licenses Out Degenerative Disc Therapy To Spine Despite Earlier Trial Failure

00:08 EDT 1 Aug 2018 | SCRIP

South Korean pharma firm licenses out to US venture Spine Biopharma novel peptide drug for degenerative disc disease YH14618, despite...

      

Related Stories

 

Original Article: Yuhan Licenses Out Degenerative Disc Therapy To Spine Despite Earlier Trial Failure

NEXT ARTICLE

More From BioPortfolio on "Yuhan Licenses Out Degenerative Disc Therapy To Spine Despite Earlier Trial Failure"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...